- Home
- ASPS vs ELEV Comparison
ASPS vs ELEV Comparison
Compare ASPS & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPS
- ELEV
- Stock Information
- Founded
- ASPS 1999
- ELEV 2019
- Country
- ASPS Luxembourg
- ELEV United States
- Employees
- ASPS N/A
- ELEV N/A
- Industry
- ASPS Other Consumer Services
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- ASPS Consumer Discretionary
- ELEV Health Care
- Exchange
- ASPS Nasdaq
- ELEV Nasdaq
- Market Cap
- ASPS 29.3M
- ELEV 34.0M
- IPO Year
- ASPS N/A
- ELEV 2021
- Fundamental
- Price
- ASPS $0.85
- ELEV $0.58
- Analyst Decision
- ASPS
- ELEV Strong Buy
- Analyst Count
- ASPS 0
- ELEV 5
- Target Price
- ASPS N/A
- ELEV $7.80
- AVG Volume (30 Days)
- ASPS 172.2K
- ELEV 838.0K
- Earning Date
- ASPS 10-24-2024
- ELEV 11-06-2024
- Dividend Yield
- ASPS N/A
- ELEV N/A
- EPS Growth
- ASPS N/A
- ELEV N/A
- EPS
- ASPS N/A
- ELEV N/A
- Revenue
- ASPS $153,278,000.00
- ELEV N/A
- Revenue This Year
- ASPS $15.33
- ELEV N/A
- Revenue Next Year
- ASPS $32.37
- ELEV N/A
- P/E Ratio
- ASPS N/A
- ELEV N/A
- Revenue Growth
- ASPS 5.19
- ELEV N/A
- 52 Week Low
- ASPS $0.70
- ELEV $0.42
- 52 Week High
- ASPS $4.60
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- ASPS 36.24
- ELEV 51.57
- Support Level
- ASPS $0.70
- ELEV $0.60
- Resistance Level
- ASPS $1.27
- ELEV $0.70
- Average True Range (ATR)
- ASPS 0.12
- ELEV 0.05
- MACD
- ASPS -0.04
- ELEV 0.01
- Stochastic Oscillator
- ASPS 23.95
- ELEV 48.09
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments namely Servicer and Real Estate and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource primarily serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of revenue flowing from field services and mortgage and real estate solutions.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.